ArticleCancer imaging : the official publication of the International Cancer Imaging Society2025
Diagnostic value of
Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo evaluate the accuracy of fluorodeoxyglucose positron emission tomography/computed tomography (
methodsIn this retrospective study conducted from January 2011 to September 2024, UM participants underwent PET/CT scans for follow-up or suspected recurrence. The lesion uptake were quantified by maximum standardized uptake value (SUVmax). Pathology and clinical follow-up served as reference standard.
resultsFifty-five participants (mean age, 49.2 ± 12.7; 26 females) were evaluated, and the average recurrent time was 30.7 months (IQR, 18.0-89.2). On per-patient level, 31 patients (56%) were confirmed to have metastatic lesions through pathology or clinical follow-up, of which 28/31 (90.3%) patients were successfully detected by
conclusion
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.